Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OLX Group Reports Strong FY 2025 Results With 18% Revenue Growth and 61% Profit Uplift Year-on-Year
-
B2B Stablecoin Payments Surge 30x to $3 Billion Monthly Volume in 2025
-
Tronsmart's Fiitune X30: Next-Generation Home Speaker with Spatial Audio in High Fidelity
-
Bentley Systems Wins Multiple 2025 Sustainability Delivery Awards
-
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
-
Meddelelse om ændring i porteføljeforvaltningshonorar – I&T Globale Aktier ESG Select
-
Offentliggørelse af prospekt, Investeringsforeningen SEBinvest
-
EveLab Insight Debuts Dynamic Wrinkle Detection Technology at VivaTech 2025, Shaping the Future of AI-Powered Skin Wellness
-
Share repurchase programme: Transactions of week 25 2025
-
WySE Products Launches Total Pet Kitchen, The First-of-Its-Kind Multicooker for Fresh Pet Food Preparation at Home
-
HABA celebrates 40 years of camping comfort: from a workplace to global wholesaler
-
LEADING EDGE MATERIALS' INVESTOR UPDATE AND SIGNIFICANT ACTIVITIES
-
141,959 Orion Corporation A shares converted into B shares
-
LEADING EDGE MATERIALS' INVESTOR UPDATE AND SIGNIFICANT ACTIVITIES
-
Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML
-
Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO
-
Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO
-
THEON secures c.€50 million new orders, directing revenue guidance to the upper range (€430 million)
-
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
-
Lenovo Ranks 8th in the Gartner® Supply Chain Top 25 for 2025
-
New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential
-
Caledonia Mining Corporation Plc: High Grade Drill Results at Blanket Mine
-
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
-
NBPE - Transaction in Own Shares
-
Elis: Disclosure of trading in own shares occured from June 16 to June 20, 2025
-
New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential
-
Lleida.net Wins First Latin American Tender for its Universal Signature Verification Certificate (USVC)
-
Shared Mobility Services to be Adopted by One Quarter of Global Population by 2028
-
MUDMAN BURGERS IS DEDICATED to SPREADING the GOSPEL of JESUS CHRIST!
-
Boyuan Capital (investment platform under Bosch Group) and Galbot Forged JV
-
Statement by the Texas Hemp Business Council on Governor Abbott’s Veto of SB3
-
Prosus Accelerates Growth and Profitability, with 12X Improvement in Ecommerce Adjusted EBIT and 100% Increase in Dividend
-
Naspers Accelerates Growth and Profitability, With 18X Improvement in Ecommerce Adjusted EBIT
-
CEA Opens Shanghai–Auckland–Buenos Aires "New International Land-Sea Trade Corridor" to First Bridge China and South America
-
Bybit P2P Africa Exclusive Giveaway: Thousands of Branded Merchandise and 1,800 USDT in Rewards
-
Deepcoin Integrates TradingView Webhook for Automated Perpetual Trading Execution
-
35/2025・Trifork Group: Weekly report on share buyback
-
Ares Management Acquires Minority Stake in Plenitude for €2 Billion
-
Claranova: Signature of Agreement for the Sale of the PlanetArt Business
-
Transaction in Own Shares
-
Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress
-
Galapagos Appoints Aaron Cox as Chief Financial Officer
-
Readiness for further growth
-
HIVE Digital Technologies Announces the Acquisition of 7.2 MW Toronto Data Center for Future BUZZ HPC and Sovereign AI Development
-
Xebra Announces Delay in Filing Financial Statements
-
SBC Medical Participated in 4 Investor Conferences in May and June 2025
-
Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A
-
Idorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreement
-
Start of Day Message
-
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer

